FDA Inspection 1084910 - Invitrx Therapeutics Inc. - April 03, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Invitrx Therapeutics Inc.

Record Details

This FDA Inspection record concerns Invitrx Therapeutics Inc., with an inspection on April 3, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Invitrx Therapeutics Inc.
Inspection Date: April 3, 2019
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 20c71ece-e5a6-4774-b48c-b6c6ac511713

Violation Codes10

21 CFR 1271.50(a)21 CFR 1271.75(a)(1)21 CFR 211.100(a)21 CFR 211.113(b)21 CFR 211.125(a)21 CFR 211.160(b)(3)21 CFR 211.166(a)21 CFR 211.198(a)21 CFR 211.22(a)21 CFR 211.25(a)

Full citation text and observation details available on the Dashboard.

FDA Inspection

Invitrx Therapeutics Inc.April 3, 2019